• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者抑郁筛查阳性者生存率降低。

Decreased survival in cystic fibrosis patients with a positive screen for depression.

机构信息

Children's Hospital of Richmond at Virginia Commonwealth University, 1000East Broad Street, Richmond, VA 23298, USA.

Cystic Fibrosis Foundation, 4550 Montgomery Avenue, Bethesda, MD 20814, USA.

出版信息

J Cyst Fibros. 2021 Jan;20(1):120-126. doi: 10.1016/j.jcf.2020.07.020. Epub 2020 Aug 13.

DOI:10.1016/j.jcf.2020.07.020
PMID:32800486
Abstract

BACKGROUND

The International Depression Epidemiological Study (TIDES) found elevated rates of screen positivity for depression and anxiety among individuals with cystic fibrosis (CF). Depression is associated with worse adherence and health-related quality of life in CF. We investigated the relationship with mortality.

METHODS

Subjects were untransplanted participants in TIDES 12+ years of age receiving care at one of 45 collaborating US CF care centers who completed the Hospital Anxiety and Depression Scale and/or Center for Epidemiologic Studies Depression Scale during a stable visit between 2006 and 2010. Clinical characteristics and mortality data were obtained from the CF Foundation Patient Registry. The association of a positive screen with 5-year survival was evaluated using Cox Proportional Hazards modeling.

RESULTS

Of 1005 eligible patients, 25% screened positive for depression and 34% screened positive for anxiety. Patients who screened positive for depression were more likely to be older, have a residual function mutation, public insurance, and more pulmonary exacerbations in the screening year. There were 96 deaths. The unadjusted 5-year Hazard Ratio (HR) for death among those with depression was 2.0; 95% CI (1.3, 3.0)]. When adjusted for predetermined potential confounders the HR for the entire population was 1.4; 95% CI (0.9, 2.2). The adjusted HR was higher in adults [1.6; 95% CI (1.0, 2.4)] and those screening in the severe range [2.0; 95% CI (1.2, 3.4)]. Anxiety was not associated with mortality.

CONCLUSIONS

A positive depression screen is associated with increased mortality among adults with CF. Research into the etiology of this relationship is needed.

摘要

背景

国际抑郁流行病学研究(TIDES)发现,囊性纤维化(CF)患者的抑郁和焦虑症状筛查阳性率较高。抑郁与 CF 患者的治疗依从性和健康相关生活质量下降有关。我们调查了其与死亡率的关系。

方法

TIDES 研究中的未接受移植的参与者,年龄在 12 岁及以上,在 2006 年至 2010 年期间,在稳定期于 45 家美国 CF 护理中心之一就诊时完成了医院焦虑和抑郁量表(HADS)和/或流行病学研究中心抑郁量表(CES-D)。从 CF 基金会患者注册处获取临床特征和死亡率数据。使用 Cox 比例风险模型评估阳性筛查与 5 年生存率的关系。

结果

在 1005 名合格患者中,25%的患者筛查出抑郁,34%的患者筛查出焦虑。筛查出抑郁的患者年龄较大,有残余功能突变,公共保险,以及在筛查年内更频繁的肺部恶化。有 96 人死亡。抑郁患者的未调整 5 年死亡风险比(HR)为 2.0;95%CI(1.3,3.0)。当调整所有潜在混杂因素时,整个人群的 HR 为 1.4;95%CI(0.9,2.2)。在成年人[1.6;95%CI(1.0,2.4)]和筛查处于严重程度的患者[2.0;95%CI(1.2,3.4)]中,调整后的 HR 更高。焦虑与死亡率无关。

结论

CF 成人中阳性抑郁筛查与死亡率增加有关。需要研究这种关系的病因。

相似文献

1
Decreased survival in cystic fibrosis patients with a positive screen for depression.囊性纤维化患者抑郁筛查阳性者生存率降低。
J Cyst Fibros. 2021 Jan;20(1):120-126. doi: 10.1016/j.jcf.2020.07.020. Epub 2020 Aug 13.
2
Mental Health Screening of Medically-Admitted Patients With Cystic Fibrosis.囊性纤维化住院患者的心理健康筛查。
Psychosomatics. 2018 Mar-Apr;59(2):158-168. doi: 10.1016/j.psym.2017.08.010. Epub 2017 Aug 30.
3
Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines.意大利囊性纤维化患者及其家长的抑郁和焦虑发生率:心理健康指南的实施。
Respir Med. 2020 Oct;172:106147. doi: 10.1016/j.rmed.2020.106147. Epub 2020 Sep 10.
4
Examining the Stability of the Hospital Anxiety and Depression Scale Factor Structure in Adolescents and Young Adults With Cystic Fibrosis: A Confirmatory Factor Analysis.在囊性纤维化青少年和年轻成人中检验医院焦虑和抑郁量表因子结构的稳定性:验证性因子分析。
J Pediatr Psychol. 2018 Jul 1;43(6):625-635. doi: 10.1093/jpepsy/jsx155.
5
Depression and anxiety symptoms in Spanish adult patients with cystic fibrosis: associations with health-related quality of life.西班牙成年囊性纤维化患者的抑郁和焦虑症状:与健康相关生活质量的关联
Gen Hosp Psychiatry. 2016 May-Jun;40:39-46. doi: 10.1016/j.genhosppsych.2016.02.002. Epub 2016 Feb 24.
6
Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis.对囊性纤维化的青少年和年轻成人进行抑郁和焦虑症状筛查。
Pediatr Pulmonol. 2011 Feb;46(2):153-9. doi: 10.1002/ppul.21334. Epub 2010 Nov 17.
7
Anxiety and depression in cystic fibrosis.囊性纤维化中的焦虑和抑郁
Minerva Med. 2015 Oct;106(5 Suppl 1):1-8.
8
Screening of depression and anxiety in adolescents with cystic fibrosis and caregivers in Turkey by PHQ-9 and GAD-7 questionnaires.土耳其青少年囊性纤维化患者及其照顾者的 PHQ-9 和 GAD-7 问卷进行抑郁和焦虑筛查。
Pediatr Pulmonol. 2021 Jun;56(6):1514-1520. doi: 10.1002/ppul.25295. Epub 2021 Feb 9.
9
Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic.对患者和照护者进行系统性抑郁和焦虑筛查:在囊性纤维化诊所的实施和流程改进。
BMJ Open Qual. 2021 May;10(2). doi: 10.1136/bmjoq-2020-001333.
10
Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis.德国囊性纤维化患者焦虑和抑郁症状的流行情况。
Chest. 2010 Oct;138(4):929-36. doi: 10.1378/chest.09-2940. Epub 2010 May 14.

引用本文的文献

1
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis.囊性纤维化患者的社会经济地位与药物依从性之间的关联
Pediatr Pulmonol. 2025 Aug;60(8):e71230. doi: 10.1002/ppul.71230.
2
The Impact of Personal-Level Social Networks on Treatment Adherence, Depression, Anxiety, and Perceived Stigma Among Adults with Cystic Fibrosis: An Egocentric Network Analysis.个人层面社交网络对成年囊性纤维化患者治疗依从性、抑郁、焦虑及感知耻辱感的影响:一项自我中心网络分析
Int J Behav Med. 2025 Jul 2. doi: 10.1007/s12529-025-10382-x.
3
Depression and anxiety in adolescents with cystic fibrosis in Brazil: prevalence, stability over time, and relationship with treatment adherence.
巴西囊性纤维化青少年的抑郁和焦虑:患病率、随时间的稳定性以及与治疗依从性的关系。
J Bras Pneumol. 2025 Jun 13;51(2):e20240416. doi: 10.36416/1806-3756/e20240416. eCollection 2025.
4
Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort.英国支气管扩张症全国队列中的焦虑、抑郁、身体疾病参数及健康相关生活质量
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00348-2024. eCollection 2025 May.
5
Psychosocial and mental health in cystic fibrosis in the modern era of care: time to evolve.现代护理时代囊性纤维化患者的心理社会与心理健康:是时候做出改变了。
BMJ Open Respir Res. 2025 Feb 10;12(1):e002606. doi: 10.1136/bmjresp-2024-002606.
6
Assessing the health impacts of parenthood on people with cystic fibrosis: the HOPeCF prospective cohort protocol.评估父母身份对囊性纤维化患者健康影响的前瞻性队列研究方案:HOPeCF 研究方案。
BMJ Open Respir Res. 2024 Aug 28;11(1):e002383. doi: 10.1136/bmjresp-2024-002383.
7
Who Am I? Self-concept in Adults with Cystic Fibrosis: Association with Anxiety and Depression.我是谁?成年囊性纤维化患者的自我概念:与焦虑和抑郁的关联。
J Clin Psychol Med Settings. 2025 Jun;32(2):365-374. doi: 10.1007/s10880-024-10023-7. Epub 2024 Jul 9.
8
Racial inequities and rare variants: Impact on cystic fibrosis diagnosis and treatment.种族不平等与罕见变异:对囊性纤维化诊断和治疗的影响。
J Clin Transl Endocrinol. 2024 Apr 20;36:100344. doi: 10.1016/j.jcte.2024.100344. eCollection 2024 Jun.
9
Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature.解决囊性纤维化患者的症状负担和姑息治疗需求:文献综述
Life (Basel). 2023 Jul 25;13(8):1620. doi: 10.3390/life13081620.
10
Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis.旨在改善肺部健康公平性:囊性纤维化。
Clin Chest Med. 2023 Sep;44(3):555-573. doi: 10.1016/j.ccm.2023.03.011. Epub 2023 May 8.